AMRN Q3 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$112M+103.2% YoY

Gross Profit

$87M77.4% margin

Operating Income

-$5M-4.0% margin

Net Income

-$3M-3.1% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+11.5%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$20M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$867M

Total Liabilities

$271M

Stockholders' Equity

$596M

Cash & Equivalents

$673M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$112M	$55M	+103.2%
Gross Profit	$87M	$42M	+108.1%
Operating Income	-$5M	-$22M	+79.7%
Net Income	-$3M	-$24M	+85.9%

Revenue Segments

Product

$112M100%

License

$158,0000%